107 related articles for article (PubMed ID: 36861722)
1. External validation of the PATHFx decision-support tool on Turkish patients with skeletal metastasis.
Ozkan K; Ozturan B; Karadag Z; Erol B; Alpan B; Ozger H; Gurkan V; Sofulu O; Yalcinkaya M; Okay E; Forsberg JA
Indian J Cancer; 2023 Feb; ():. PubMed ID: 36861722
[TBL] [Abstract][Full Text] [Related]
2. External Validation of PATHFx Version 3.0 in Patients Treated Surgically and Nonsurgically for Symptomatic Skeletal Metastases.
Anderson AB; Wedin R; Fabbri N; Boland P; Healey J; Forsberg JA
Clin Orthop Relat Res; 2020 Apr; 478(4):808-818. PubMed ID: 32195761
[TBL] [Abstract][Full Text] [Related]
3. Can A Multivariate Model for Survival Estimation in Skeletal Metastases (PATHFx) Be Externally Validated Using Japanese Patients?
Ogura K; Gokita T; Shinoda Y; Kawano H; Takagi T; Ae K; Kawai A; Wedin R; Forsberg JA
Clin Orthop Relat Res; 2017 Sep; 475(9):2263-2270. PubMed ID: 28560532
[TBL] [Abstract][Full Text] [Related]
4. Can We Estimate Short- and Intermediate-term Survival in Patients Undergoing Surgery for Metastatic Bone Disease?
Forsberg JA; Wedin R; Boland PJ; Healey JH
Clin Orthop Relat Res; 2017 Apr; 475(4):1252-1261. PubMed ID: 27909972
[TBL] [Abstract][Full Text] [Related]
5. Predicting survival of patients with spinal metastatic disease using PathFx 3.0 - A validation study of 668 patients in Sweden.
Carrwik C; Tsagkozis P; Wedin R; Robinson Y
Brain Spine; 2022; 2():101669. PubMed ID: 36506283
[TBL] [Abstract][Full Text] [Related]
6. Validation of PATHFx 2.0: An open-source tool for estimating survival in patients undergoing pathologic fracture fixation.
Overmann AL; Clark DM; Tsagkozis P; Wedin R; Forsberg JA
J Orthop Res; 2020 Oct; 38(10):2149-2156. PubMed ID: 32492213
[TBL] [Abstract][Full Text] [Related]
7. How do we estimate survival? External validation of a tool for survival estimation in patients with metastatic bone disease-decision analysis and comparison of three international patient populations.
Piccioli A; Spinelli MS; Forsberg JA; Wedin R; Healey JH; Ippolito V; Daolio PA; Ruggieri P; Maccauro G; Gasbarrini A; Biagini R; Piana R; Fazioli F; Luzzati A; Di Martino A; Nicolosi F; Camnasio F; Rosa MA; Campanacci DA; Denaro V; Capanna R
BMC Cancer; 2015 May; 15():424. PubMed ID: 25998535
[TBL] [Abstract][Full Text] [Related]
8. Prediction of survival after surgical management of femoral metastatic bone disease - A comparison of prognostic models.
Meares C; Badran A; Dewar D
J Bone Oncol; 2019 Apr; 15():100225. PubMed ID: 30847272
[TBL] [Abstract][Full Text] [Related]
9. External Validation and Optimization of the SPRING Model for Prediction of Survival After Surgical Treatment of Bone Metastases of the Extremities.
Sørensen MS; Gerds TA; Hindsø K; Petersen MM
Clin Orthop Relat Res; 2018 Aug; 476(8):1591-1599. PubMed ID: 30020148
[TBL] [Abstract][Full Text] [Related]
10. Can a Bayesian belief network for survival prediction in patients with extremity metastases (PATHFx) be externally validated in an Asian cohort of 356 surgically treated patients?
Hsieh HC; Lai YH; Lee CC; Yen HK; Tseng TE; Yang JJ; Ling SY; Hu MH; Hou CH; Yang RS; Wedin R; Forsberg JA; Lin WH
Acta Orthop; 2022 Sep; 93():721-731. PubMed ID: 36083697
[TBL] [Abstract][Full Text] [Related]
11. Machine learning algorithms to estimate 10-Year survival in patients with bone metastases due to prostate cancer: toward a disease-specific survival estimation tool.
Anderson AB; Grazal C; Wedin R; Kuo C; Chen Y; Christensen BR; Cullen J; Forsberg JA
BMC Cancer; 2022 Apr; 22(1):476. PubMed ID: 35490227
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.
Qiu PF; Liu JJ; Wang YS; Yang GR; Liu YB; Sun X; Wang CJ; Zhang ZP
Jpn J Clin Oncol; 2012 Nov; 42(11):1002-7. PubMed ID: 23100610
[TBL] [Abstract][Full Text] [Related]
13. Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison.
Kuo YL; Chen WC; Yao WJ; Cheng L; Hsu HP; Lai HW; Kuo SJ; Chen DR; Chang TW
Int J Surg; 2013; 11(7):538-43. PubMed ID: 23707626
[TBL] [Abstract][Full Text] [Related]
14. Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram.
Chue KM; Yong WS; Thike AA; Ahmed SS; Li HH; Wong CY; Ho GH; Madhukumar P; Tan BK; Ong KW; Tan PH
J Clin Pathol; 2014 Feb; 67(2):112-9. PubMed ID: 24048026
[TBL] [Abstract][Full Text] [Related]
15. Comparison between different prognostic models to be used for metastatic bone disease on appendicular skeleton in a Chilean population.
Alfaro PA; Delgado J; Dumas A; Mesa C; Wevar O; Herrera C; Padilla F; Botello E
Eur J Orthop Surg Traumatol; 2021 Dec; 31(8):1657-1662. PubMed ID: 34677661
[TBL] [Abstract][Full Text] [Related]
16. [Risk factors of non-sentinel lymph node metastasis and performance of MSKCC nomogramin breast cancer patients with metastatic sentinel lymph node].
Huang J; Chen X; Fei X; Huang O; Wu J; Zong Y; Zhu L; He J; Chen W; Li Y; Shen K
Zhonghua Wai Ke Za Zhi; 2015 Dec; 53(12):941-6. PubMed ID: 26850667
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of sorafenib correlates with Memorial Sloan-Kettering Cancer Center (MSKCC) risk classification and bone metastasis in Chinese patients with metastatic renal cell carcinoma.
Zhang Y; Li Y; Cai Y; Wang K; Li H
Cell Oncol (Dordr); 2016 Feb; 39(1):15-21. PubMed ID: 26597814
[TBL] [Abstract][Full Text] [Related]
18. Preoperative ultrasound-based radiomics score can improve the accuracy of the Memorial Sloan Kettering Cancer Center nomogram for predicting sentinel lymph node metastasis in breast cancer.
Zha HL; Zong M; Liu XP; Pan JZ; Wang H; Gong HY; Xia TS; Liu XA; Li CY
Eur J Radiol; 2021 Feb; 135():109512. PubMed ID: 33429302
[TBL] [Abstract][Full Text] [Related]
19. Assessment of an existing and modified model for predicting non sentinel lymph node metastasis in breast cancer patients with positive sentinel node biopsy.
Al-Masri M; Darwazeh G; El-Ghanem M; Hamdan B; Sughayer M
Gulf J Oncolog; 2013 Jan; 1(13):15-22. PubMed ID: 23339977
[TBL] [Abstract][Full Text] [Related]
20. External validation of Memorial Sloan Kettering Cancer Center nomogram and prediction of optimal candidate for lymph node dissection in clinically localized prostate cancer.
Milonas D; Venclovas Z; Muilwijk T; Jievaltas M; Joniau S
Cent European J Urol; 2020; 73(1):19-25. PubMed ID: 32395318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
